The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothers
Abstract
Summary. In infants born to hepatitis B surface antigen (HBsAg)–positive mothers, failure after passive–active immunization still occurs. The role of maternal hepatitis B DNA level and other risk factors in this setting remains unclear. This study retrospectively evaluated virologic and other risk factors associated with immunoprophylaxis failure in infants born to HBsAg‐positive mothers. Between January 2007 and March 2010, we reviewed the clinical and virologic tests in 869 mother–infant pairs. All infants received the identical passive–active immunization schedule after birth. The failure infants (HBsAg positive at 7–12 months of age) were compared to infants who were HBsAg negative when tested during this time period. Among 869 infants, 27 (3.1%) infants were immunoprophylaxis failures and the other 842 (96.9%) infants remained HBsAg negative. When mothers’ pre‐delivery HBV DNA levels were stratified to <6, 6–6.99, 7–7.99 and ≥8 log 10 copies/mL, the corresponding rates of immunoprophylaxis failure were 0%, 3.2% (3/95), 6.7% (19/282) and 7.6% (5/66), respectively (P < 0.001 for the trend). All failure infants were born to hepatitis B e antigen (HBeAg)–positive mothers. Multivariate logistic regression analysis identified maternal HBV DNA levels [odds ratio (OR) = 1.88, 95% confidence interval (CI): 1.07–3.30] and detectable HBV DNA in the cord blood (OR = 39.67, 95% CI: 14.22–110.64) as independent risk factors for immunoprophylaxis failure. All failure infants were born to HBeAg‐positive mothers with HBV DNA levels ≥6 log 10 copies/mL. The presence of HBV DNA in cord blood predicted failure to passive–active immunization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Lavanchy, D. (2004) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00487.x · Cited by 2,642
Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372406 · Cited by 2,569
Lai, C. L., Ratziu, V., Yuen, M.-F., & Poynard, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15108-2 · Cited by 1,727
Hepatitis B Virus Infection: Epidemiology and Vaccination
Shepard, C. W. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj009 · Cited by 1,148
Weinbaum, C. M., Mast, E. E., & Ward, J. W. (2009) · Hepatology · doi:10.1002/hep.22882 · Cited by 815
Prevention and Control of Influenza: Recommendation of the Immunization Practices Advisory Committee
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-560 · Cited by 810
THE e ANTIGEN AND VERTICAL TRANSMISSION OF HEPATITIS B SURFACE ANTIGEN
BEASLEY, R. P., TREPO, C., STEVENS, C. E., & SZMUNESS, W. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112370 · Cited by 611
Risks of chronicity following acute hepatitis B virus infection: a review.
Hyams, K. C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.992 · Cited by 521
Lee, C., Gong, Y., Brok, J., Boxall, E. H., & Gluud, C. (2006) · BMJ · doi:10.1136/bmj.38719.435833.7c · Cited by 402
Xu, W. ‐., Cui, Y. ‐., Wang, L., Yang, H., Liang, Z. ‐., Li, X. ‐., Zhang, S. ‐., Qiao, F. ‐., Campbell, F., Chang, C. ‐., et al. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01056.x · Cited by 387
Perinatal transmission of hepatitis B virus: an Australian experience
Wiseman, E., Fraser, M. A., Holden, S., Glass, A., Kidson, B. L., Heron, L. G., Maley, M. W., Ayres, A., LOCARNINI, S. A., & Levy, M. T. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02524.x · Cited by 378
Ni, Y., Huang, L., Chang, M., Yen, C., Lu, C., You, S., Kao, J., Lin, Y., Chen, H., Hsu, H., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.055 · Cited by 348
Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein
Visvanathan, K., Skinner, N. A., Thompson, A. J. V., Riordan, S. M., Sozzi, V., Edwards, R., Rodgers, S., Kurtovic, J., Chang, J., Lewin, S., et al. (2007) · Hepatology · doi:10.1002/hep.21482 · Cited by 339
Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
Chen, D.-S. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.002 · Cited by 261
Epidemiology of hepatitis B virus infection in the Asia–Pacific region
Chen, C., Wang, L., & Yu, M. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02124.x · Cited by 259
Chien, Y.-C. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj010 · Cited by 207
Hepatitis B vaccines: WHO position paper—Recommendations
(2010) · Vaccine · doi:10.1016/j.vaccine.2009.10.110 · Cited by 202
del Canho, R., Grosheide, P. M., Mazel, J. A., Heijtink, R. A., Hop, W. C. J., Gerards, L. J., de Gast, G. C., Fetter, W. P. F., Zwijneberg, J., & Schalm, S. W. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00080-7 · Cited by 190
Singh, A. E., Plitt, S. S., Osiowy, C., Surynicz, K., Kouadjo, E., Preiksaitis, J. K., & Lee, B. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01333.x · Cited by 106
Yang, Y., Liu, C., CHEN, T.-J., Lee, M.-F., Chen, S.-H., Shih, H., & Chang, M. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000073123.93220.a8 · Cited by 62
Management of Chronic Hepatitis B in Pregnancy
Buchanan, C., & Tran, T. T. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.05.008 · Cited by 51
Cited by
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
AASLD guidelines for treatment of chronic hepatitis B
Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2016) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,006
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
Pan, C. Q., Duan, Z., Dai, E., Zhang, S., Han, G., Wang, Y., Zhang, H., Zou, H., Zhu, B., Zhao, W., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1508660 · Cited by 573
Self-citationHepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
Nguyen, M. H., Wong, G., Gane, E., Kao, J.-H., & Dusheiko, G. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-19 · Cited by 554
Metadata
- Authors
- Zou, H., Chen, Y., Duan, Z., Zhang, H., & Pan, C.
- Venue
- Journal of Viral Hepatitis
- Publisher
- Wiley
- Published
- 2011-08
- Volume
- 19
- Issue
- 2
- Pages
- e18-25
- ISSN
- 1352-0504 (ISSN-L)
- 1365-2893
- OpenAlex
- W1599401828
- Cited by
- 366
- References
- 22
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.